Patents matching “ala”

IT 202100001169

GEL MUCOADESIVO BUCCALE CONTENENTE PROBIOTICI PER USO NELLA PREVENZIONE E NEL TRATTAMENTO DELLE MALATTIE PARODONTALI.

ALFASIGMA SPA [IT] · Granted Jul 27, 2022 · Expires Jul 22, 2042

US 11396571

Polymers including galactose based blocks and uses thereof

Regents of the University of Minnesota · Granted Jul 26, 2022 · Expires Jul 21, 2042

CA 3207179

METHODES DE TRAITEMENT DE LA MALADIE DE CROHN ET DE LA COLITE ULCEREUSE

ABBVIE INC [US] · Granted Jul 14, 2022 · Expires Jul 9, 2042

CA 3201259

MASITINIB POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER

AB SCIENCE [FR] · Granted Jun 23, 2022 · Expires Jun 18, 2042

WO 2022131944

RÉGIMES DE TRAITEMENT DE LA MALADIE DE PARKINSON IDIOPATHIQUE PRÉCOCE

BIAL PORTELA & CA SA [PT] · Granted Jun 23, 2022 · Expires Jun 18, 2042

US 11357782

Treprostinil administration by inhalation

United Therapeutics Corporation · Granted Jun 14, 2022 · Expires Jun 9, 2042

WO 2022081033

OPICAPONE ET LÉVODOPA POUR LE TRAITEMENT DE LA MALADIE DE PARKINSON

BIAL PORTELA & Cª S A [PT] · Granted Apr 21, 2022 · Expires Apr 16, 2042

US 11253506

Compounds, compositions and methods for preventing and/or treating chlorine inhalation toxicity and/or injury

The Regents of the University of Colorado, a Body Corporate · Granted Feb 22, 2022 · Expires Feb 17, 2042

US 11207283

Inactivators of toxoplasma gondii ornithine aminotransferase for treating toxoplasmosis and malaria

Northwestern University · Granted Dec 28, 2021 · Expires Dec 23, 2041

CA 3177888

ANTICORPS ANTI-HEMOJUVELINE (HJV) DE TRAITEMENT DE L'ANEMIE DE MALADIES CHRONIQUES

DISC MEDICINE INC [US] · Granted Nov 18, 2021 · Expires Nov 13, 2041

US 11149000

Carbamoyl phenylalaninol compounds and uses thereof

Jazz Pharmaceuticals Ireland Limited · Granted Oct 19, 2021 · Expires Oct 14, 2041

CA 3174748

UTILISATION DE MASITINIB POUR LE TRAITEMENT DE LA MALADIE A CORONAVIRUS 2019 (COVID-19)

AB SCIENCE [FR] · Granted Oct 14, 2021 · Expires Oct 9, 2041

US 11116823

Treatment of α-galactosidase a deficiency

Takeda Pharmaceutical Company Limited · Granted Sep 14, 2021 · Expires Sep 9, 2041

US 11072600

Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer

The Regents of the University of California · Granted Jul 27, 2021 · Expires Jul 22, 2041

US 11065264

Metal-olsalazine coordination polymers for medical applications

The Regents of the University of California · Granted Jul 20, 2021 · Expires Jul 15, 2041

US 11028392

Compositions and methods for inhibiting expression of the ALAS1 gene

Alnylam Pharmaceuticals, Inc. · Granted Jun 8, 2021 · Expires Jun 3, 2041

US 11013791

NYVAC-based plasmodium malaria vaccine

The Government of the United States, as represented by the Secretary of the Army · Granted May 25, 2021 · Expires May 20, 2041

US 10988472

Compounds and method for blocking transmission of malarial parasite

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 27, 2021 · Expires Apr 22, 2041

US 10968452

Polynucleotide agents targeting aminolevulinic acid synthase-1 (ALAS1) and uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Apr 6, 2021 · Expires Apr 1, 2041

WO 2021048135

COMBINAISONS PHARMACEUTIQUES COMPRENANT UN FURAZANOBENZIMIDAZOLE ET UN AGONISTE DE CD40 POUR UNE UTILISATION DANS LE TRAITEMENT DE MALADIES NÉOPLASIQUES

BASILEA PHARM INT AG [CH] · Granted Mar 18, 2021 · Expires Mar 13, 2041

US 10946027

Tianeptine oxalate salts and polymorphs

TONIX PHARMA LIMITED · Granted Mar 16, 2021 · Expires Mar 11, 2041

US 10888558

Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

The Government of the United States, as represented by the Secretary of the Army · Granted Jan 12, 2021 · Expires Jan 7, 2041

US 10889576

Phthalazinone compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC · Granted Jan 12, 2021 · Expires Jan 7, 2041

US 10881669

Inhibitors of the plasmodial surface anion channel as antimalarials

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 5, 2021 · Expires Dec 31, 2040